Top Houston, TX Pharmaceutical Companies (28)
Don't see your company?
Create a company profile
Anton Paar develops, produces, distributes and provides support for analytical instruments used in research, development and quality control worldwide. Ever since Mr. Anton Paar founded his one-man workshop in 1922, the Austrian based company has continuously found new ways to merge high-precision engineering with scientific curiosity. The company currently has more than 3500 employees and is active in over 170 countries worldwide. Anton Paar is the world market leader in the field of density measurement, the determination of dissolved CO2 and the analysis of materials’ deformation and flow behavior. Customers of Anton Paar include the largest international soft drink producers and breweries, petroleum and food companies, the chemical and pharmaceutical industries, Formula 1 racing teams and many more. Our innovation builds on research and development, but goes beyond technology and involves all of Anton Paar’s employees. Innovation is the art of finding answers before the question is asked. Customers deserve reliable application solutions which are precise, economic and easy to use. Anton Paar customers can always expect more.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius’ product portfolio includes seclidemstat, a reversible LSD1 inhibitor, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule targeted protein degrader. Seclidemstat is currently in a Phase 1/2 clinical trial for relapsed/refractory Ewing sarcoma and select additional sarcomas that share a similar biology to Ewing sarcoma, also referred to as Ewing-related or FET-rearranged sarcomas. Seclidemstat has received Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation for Ewing sarcoma from the U.S. Food and Drug Administration. Salarius is also exploring seclidemstat’s potential in several cancers with high unmet medical need, with a second Phase 1/2 clinical study in hematologic cancers, initiated by MD Anderson Cancer Center. Salarius has received financial support from the National Pediatric Cancer Foundation to advance the Ewing sarcoma clinical program and was also a recipient of a Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, please visit salariuspharma.com or follow Salarius on Twitter and LinkedIn.
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
Tech Pharmacy Services, Inc., doing business as Advanced Pharmacy, designs, develops, implements, and services technology-based solutions.
Clinical stage pharmaceutical company developing topical, non-narcotic medications to treat pain.
We are located near the Texas Medical Center in Houston, Texas. Under the leadership of Alice S. Weissfeld, Ph.D., D (ABMM), and Paula H. Vance, SM(NRM), SM(ASCP), CLS(M), msi has remained in the forefront of microbiology testing since 1984 and maintains a reputation for scientifically reliable testing. Originally founded as a clinical microbiology reference laboratory, msi subsequently expanded its services to include environmental microbiology and pharmaceutical and diagnostic trials. MSI has built a strong reputation as a central microbiology lab. Our heritage of scientific and therapeutic excellence translates to the highest standards for our sponsors. Dr. Weissfeld reviews all testing methods and schema to ensure the most efficient and effective study design. We routinely add new tests and evaluate industry trends in order to build our capabilities to support client needs. We offer scientific expertise related to: Protocol consultation Veterinarian Clinical Trials Medical Device Pharmaceutical Please contact us today to discuss your Microbiology needs for any type of clinical trial or USP Compliance.
Wells Pharma is a registered FDA 503B Outsourcing Facility providing medications to hospitals and surgical centers. Our mission is to consistently supply top quality products with the best customer service in the industry.
Animal Life Sciences focuses on the development and commercialization of treatments for cats and dogs based on human cancer technologies.
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Pulmotect develops products that boost the innate immune system to protect against a wide range of lung infections.
Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.
Nano3D Biosciences develops products for in vitro cell culturing applications.
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
PCCA is a complete resource for compounding pharmacies. Our members are nearly 4,000 community pharmacists in the United States, Canada, Australia and other countries around the world. We were incorporated in 1981 by a network of pharmacists who recognized the need to help patients requiring customized medications.
Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
1molar inc. is a biomedical technology company.
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Memgen is developing viral immunotherapies to harness the power of the immune system to cure cancer and protect people from COVID-19
Work Your Passion. Live Your Purpose.
